The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-FTSE 100 ends flat ahead of Fed decision; GSK slumps on weak earnings

Wed, 29th Jul 2020 09:04

(For a live blog on European stocks, type LIVE/ in an Eikon
news window)

* GSK hits 15-week low on profit miss

* Barclays falls as loan loss provisions grow

* Next jumps on posting smaller-than-feared slump in sales

* Consumer, tech stocks weigh on mid-cap index

* FTSE 100 up 0.04%, FTSE 250 down 0.2%
(Updates to close)

By Sagarika Jaisinghani and Susan Mathew

July 29 (Reuters) - The FTSE 100 ended flat on Wednesday as
investors held out for more stimulus from the U.S. Congress and
the Federal Reserve, while GlaxoSmithKline, Barclays and Taylor
Wimpey slid on weak quarterly earnings.

The world's largest vaccine maker, GSK, slumped 3.2%
to hit a 15-week low after missing second-quarter profit
estimates under the effect of coronavirus lockdowns, dragging
the healthcare index down 1.8%.

Kicking off the quarterly earnings season for UK banks,
Barclays set aside a higher-than-expected 1.6 billion
pounds ($2.07 billion) to cover a possible rise in loan losses
due to the COVID-19 pandemic. Its shares fell 6.1%.

But a 7.7% jump for Next Plc helped the blue-chip
FTSE 100 end in positive territory as the retailer
reported a smaller-than-feared slump in second-quarter sales.

The mid-cap FTSE 250 was off 0.2%, weighed by losses
in consumer discretionary, financial and tech-related stocks.

The Fed is expected to sound reassuringly accommodative at
its policy review due at 2 p.m. ET (1800 GMT), followed by Chair
Jerome Powell's press conference, but investors have turned wary
over political wrangling between U.S. Democrats and Republicans
on a coronavirus relief plan.

"Not much will come of (the Fed meeting) in terms of policy.
That said, we think a sober assessment from the Fed or Powell
could challenge risk sentiment," said Mazen Issa, senior FX
strategist at TD Securities.

"With COVID cases ravaging the U.S. and the job market
stalling, there is a risk that Powell sounds more bearish than
dovish."

Uncertainty about global efforts to contain the pandemic
stalled a three-month rally for the FTSE 100 in July. Although
recent economic data has shown a revival in business activity
with the lifting of nationwide lockdowns, traders are concerned
about the damage from another possible shutdown.

Homebuilder Taylor Wimpey Plc shed 8.1% on saying it
expected to complete around 40% fewer homes in 2020.

(Reporting by Sagarika Jaisinghani in Bengaluru; editing by
Uttaresh.V and Kevin Liffey)

More News
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 17:10

Miners, personal goods stocks drag FTSE 100 to two-week low

Burberry slips on rating downgrade

*

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 12:10

LONDON MARKET MIDDAY: Stocks down before Fed minutes and US PMI data

(Alliance News) - Stock prices in London were down at midday on Wednesday, in cautious trade ahead of key US data and central bank minutes in the afternoon.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
29 Dec 2023 13:01

LONDON MARKET CLOSE: UK equities outclassed by other markets in 2023

(Alliance News) - Stock prices in London closed mixed on Friday, the final trading day of 2023, as the annual returns from UK equities were outshone by international markets.

Read more
20 Dec 2023 13:29

GSK buys rights to Hansoh Pharma antibody-drug conjugate

(Sharecast News) - GSK has agreed to buy the rights to an antibody-drug conjugate (ADC) - HS-20093 - from Chinese biopharmaceutical group Hansoh Pharma.

Read more
19 Dec 2023 15:36

German court quashes CureVac patent after challenge by BioNTech

CureVac shares drop 40%Dispute over intellectual property with BioNTech to continue

*

Read more
18 Dec 2023 17:21

Energy stocks lift UK's FTSE 100, Vodafone shines

Vodafone jumps as Iliad offers to merge Italian units

*

Read more
18 Dec 2023 10:07

GSK's dostarlimab trial in endometrial cancer meets primary endpoint

(Alliance News) - GSK PLC on Monday said a trial of dostarlimab in combination with niraparib for treating endometrial cancer has met its primary endpoint.

Read more
18 Dec 2023 07:55

LONDON BRIEFING: Games Workshop seals Amazon deal for Warhammer 40,000

(Alliance News) - Stocks in London were set to retreat slightly on Monday, in line with equity markets in Asia, at the start of the last week before the Christmas holidays.

Read more
18 Dec 2023 07:18

GSK sees success in Jemperli endometrial cancer trial

(Sharecast News) - GSK released positive headline results from the planned analysis of its trial of Jemperli in endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.